Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Buy
60
UVE Quote, Financials, Valuation and Earnings
Last price:
$27.10
Seasonality move
:
9.98%
Day range:
$26.62 - $27.25
52-week range:
$16.50 - $27.25
Dividend yield:
2.36%
P/E ratio:
11.85x
P/S ratio:
0.51x
P/B ratio:
1.81x
Volume:
225.7K
Avg. volume:
255.4K
1-year change:
39.11%
Market cap:
$763.8M
Revenue:
$1.5B
EPS (TTM):
$2.29
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Universal Insurance Holdings has 6.85% upside to fair value with a price target of $29.00 per share.
UVE vs. S&P 500
-
Over the past 5 trading days, Universal Insurance Holdings has overperformed the S&P 500 by 1.03% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Universal Insurance Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Universal Insurance Holdings has grown year-over-year revenues for 14 quarters straight. In the most recent quarter Universal Insurance Holdings reported revenues of $394.9M.
Earnings Growth
-
Universal Insurance Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Universal Insurance Holdings reported earnings per share of $1.44.
Enterprise value:
267.6M
EV / Invested capital:
--
Price / LTM sales:
0.51x
EV / EBIT:
2.72x
EV / Revenue:
0.17x
PEG ratio (5yr expected):
1.74x
EV / Free cash flow:
1.13x
Price / Operating cash flow:
3.32x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.57%
Net Income Margin (TTM):
4.31%
Return On Equity:
17.07%
Return On Invested Capital:
13.55%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1.4B | $1.5B | $368M | $394.9M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$0.51 | $2.55 | $2.29 | $1.14 | $1.44 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.5B | $1.5B | $2.2B | $773.8M | $1.2B | |
| Total Assets | $1.7B | $1.7B | $2.6B | $2.1B | $2.7B | |
| Current Liabilities | $51.2M | $36.2M | $202.4M | $145.5M | $169.5M | |
| Total Liabilities | $1.3B | $1.4B | $2.2B | $1.8B | $2.3B | |
| Total Equity | $454.7M | $396.3M | $321.8M | $364.7M | $422.4M | |
| Total Debt | $8.1M | $103.4M | $102.6M | $101.8M | $101.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $301.3M | $204.1M | $241.2M | $82.9M | $186.8M | |
| Cash From Investing | -$103M | -$87M | -$195.3M | -$74.4M | -$41.5M | |
| Cash From Financing | -$33.5M | -$51M | -$44.1M | -$9.5M | -$6.5M | |
| Free Cash Flow | $297.9M | $197.5M | $235.9M | $79.6M | $185.5M | |
UVE
Sector
Market Cap
$763.8M
$608.2M
Price % of 52-Week High
99.6%
87%
Dividend Yield
2.36%
2.03%
Shareholder Yield
5.88%
4.07%
1-Year Price Total Return
39.11%
10.08%
Beta (5-Year)
0.829
0.587
Dividend yield:
2.36%
Annualized payout:
$0.77
Payout ratio:
33.77%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$26.65
200-day SMA
Buy
Level
$21.64
Bollinger Bands (100)
Buy
Level
19.87 - 24.69
Chaikin Money Flow
Buy
Level
36.1M
20-day SMA
Buy
Level
$26.17
Relative Strength Index (RSI14)
Buy
Level
69.48
ADX Line
Buy
Level
35.39
Williams %R
Sell
Level
-4.6777
50-day SMA
Buy
Level
$24.22
MACD (12, 26)
Buy
Level
0.80
25-day Aroon Oscillator
Buy
Level
92
On Balance Volume
Neutral
Level
19M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.5571)
Sell
CA Score
(Annual)
Level (-1.7356)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.8523)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.
Stock Forecast FAQ
In the current month, UVE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The UVE average analyst price target in the past 3 months is $29.00.
-
Where Will Universal Insurance Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Universal Insurance Holdings share price will rise to $29.00 per share over the next 12 months.
-
What Do Analysts Say About Universal Insurance Holdings?
Analysts are divided on their view about Universal Insurance Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Universal Insurance Holdings is a Sell and believe this share price will drop from its current level to $29.00.
-
What Is Universal Insurance Holdings's Price Target?
The price target for Universal Insurance Holdings over the next 1-year time period is forecast to be $29.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is UVE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Universal Insurance Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of UVE?
You can purchase shares of Universal Insurance Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Universal Insurance Holdings shares.
-
What Is The Universal Insurance Holdings Share Price Today?
Universal Insurance Holdings was last trading at $27.10 per share. This represents the most recent stock quote for Universal Insurance Holdings. Yesterday, Universal Insurance Holdings closed at $27.14 per share.
-
How To Buy Universal Insurance Holdings Stock Online?
In order to purchase Universal Insurance Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
